Chapter 19 - The Inspection Nobody ExpectedFederal inspectors arrived at Halcyon at 6:12 the following morning.

No warning.
No courtesy call.
Four black government vehicles rolled through the security gates before sunrise.
By six-thirty, every production line associated with the pediatric monitor had been frozen pending inspection.
The lead investigator introduced herself as Dr. Rebecca Sloan.
She was short, serious, and completely unimpressed by executive titles.
“Mr. Mercer?”
“Yes.”
“We received allegations involving falsified durability tests, manipulated sensor readings, and concealed prototype failures.”
“None of those allegations are true.”
“That is what we are here to determine.”
I nodded.
“You’ll have complete access.”
Maria glanced at me.
That answer surprised the inspectors.
Companies under investigation usually called lawyers first.
I called technicians.
“Maria, open everything.”
“Everything?”
“Everything.”
Dr. Sloan studied me.
“You understand that includes internal failures?”
“Yes.”
“Rejected prototypes?”
“Yes.”
“Employee communications?”
“If legally permitted.”
“Supplier records?”
“Every invoice.”
She nodded once.
“Good.”
For fourteen hours, Halcyon opened its doors.
The inspectors examined failed prototypes.
They interviewed technicians privately.
They compared raw sensor logs with official reports.
They inspected calibration equipment.
They pulled random units from storage and tested them without warning.
Nobody interfered.
Nobody coached employees.
Nobody deleted anything.
At eight that evening, I found Dr. Sloan standing beside Line Four.
She was holding one of our rejected prototype boards.
“Your team documented seventeen failures on this revision.”
“Yes.”
“Most companies would classify some of these as developmental anomalies.”
“We call failures failures.”
She looked at me.
“Why?”
“Because machines don’t care what terminology makes executives comfortable.”
For the first time, she almost smiled.
Then Marcus hurried toward us.
“Daniel.”
Something was wrong.
“What?”
“We found something.”
He led Maria and me into the server room.
A cybersecurity specialist pointed at a monitor.
“Someone accessed the prototype database remotely eleven days ago.”
“From outside Halcyon?”
“Yes.”
“Did they change anything?”
“That’s the strange part.”
He opened two files.
One was our original testing record.
The second appeared identical.
Until he highlighted several rows.
Failure percentages had been altered.
Successful durability tests had been changed to failures.
Temperature readings had been manipulated.
Maria whispered, “They planted evidence.”
The specialist nodded.
“And whoever did it used executive credentials.”
“Whose?”
He enlarged the login record.
My name appeared.
DANIEL MERCER — ADMINISTRATOR ACCESS.
My stomach turned cold.
Dr. Sloan stood behind us.
She had followed.
Nobody spoke.
Finally she asked, “Mr. Mercer, where were you eleven nights ago at 2:13 AM?”
“At home.”
“Can you prove it?”
“I was asleep.”
Maria stepped forward.
“Daniel didn’t do this.”
Dr. Sloan raised a hand.
“I’m not accusing anyone. I’m collecting facts.”
The cybersecurity specialist continued searching.
Then he frowned.
“Wait.”
“What?”
“The login originated through Daniel’s credentials, but authentication was bypassed.”
“Meaning?”
“Someone cloned his security token.”
Marcus swore quietly.
Only a handful of people had ever possessed enough technical access to do that.
Victor.
Brent.
Gregory.
And several former IT executives.
Most had been investigated after Christmas.
One had disappeared.
I remembered the name.
“Evan Pike.”
Marcus looked at me.
Halcyon’s former vice president of information systems.
He had resigned three weeks before Victor was fired.
At the time, nobody considered it suspicious.
Now it looked like an escape.
Sarah called federal investigators.
Within hours, they discovered Evan Pike had joined a consulting company after leaving Halcyon.
That company was owned by Vale Capital.
By sunrise, Dr. Sloan had enough information to separate the planted files from Halcyon’s authentic testing records.
The inspection continued.
But the investigation had changed direction.
At ten the next morning, Harrison Vale appeared on television.
He expressed “deep concern” about Halcyon’s regulatory situation.
He told investors his acquisition could “restore confidence.”
I watched the interview from the cafeteria.
Maria threw a napkin at the television.
“He creates the fire and then offers to sell us the extinguisher.”
“Looks that way.”
Arthur entered.
“We have a bigger problem.”
“How much bigger?”
“Vale’s position is forty-three percent.”
Maria stopped moving.
Seven days earlier, it had been seventeen.
Now forty-three.
The shareholder meeting was nineteen days away.
Arthur sat down.
“Daniel, some board members want negotiations.”
“No.”
“If he reaches fifty-one—”
“He won’t.”
Arthur looked tired.
“You don’t know that.”
“No,” I admitted. “But I know something Harrison doesn’t.”
“What?”
I looked through the cafeteria windows toward the production floor.
“Our people know what they’re fighting for.”
That afternoon, Dr. Sloan gathered the senior team.
Her preliminary conclusion was clear.
Halcyon’s authentic safety data had not been falsified.
Someone had attempted to manipulate internal records after testing was completed.
The pediatric monitor itself had passed every verified benchmark.
Maria hugged the nearest technician.
But Dr. Sloan wasn’t finished.
“There’s something else.”
She placed a small circuit component on the table.
“We randomly tested supplier components from your warehouse.”
I recognized it immediately.
A cardiac sensor chip.
“What about it?”
“This shipment is counterfeit.”
Silence.
I stared at the component.
“Which supplier?”
Dr. Sloan slid an invoice toward me.
The supplier name hit me like a punch.
MIDWEST PRECISION ELECTRONICS.
We had used them for twelve years.
Maria shook her head.
“Impossible.”
Dr. Sloan pointed to the manufacturing code.
“These components did not come from Midwest Precision.”
“Then where?”
She looked directly at me.
“Northstar Meridian.”
The room went silent.
Someone had put Northstar components inside Halcyon’s warehouse.
Not just to embarrass us.
If those parts reached production, patients could die.
May you like
This wasn’t a hostile takeover anymore.
It was sabotage.
Related Stories